Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype
Publication date
18/02/2020Metadata
Show full item recordCitation
Porter , R J , Murray , G I , Price , D P , Petty , R D & McLean , M H 2020 , ' Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype ' , British Journal of Cancer , vol. 122 , pp. 545-554 . https://doi.org/10.1038/s41416-019-0685-1
Rights
This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).